3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
71
Recurrence
7
Smoldering Multiple Myeloma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Immunoglobulin Light-chain Amyloidosis
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Neoplasms, Plasma Cell
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Plasmacytoma
1
Paraproteinemias
1
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
asciminib
15
Cyclophosphamide
12
fludarabine phosphate
10
Mycophenolic Acid
9
fludarabine
8
nilotinib
7
Whole-Body Irradiation
7
Imatinib Mesylate
6
Dasatinib
6
Tacrolimus
5
Sirolimus
5
Cyclosporine
5
venetoclax
4
bosutinib
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
ponatinib
3
Thiotepa
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
Busulfan
3
thymoglobulin
2
ruxolitinib
2
Specimen Handling
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Blood Component Removal
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
daratumumab
×
90 days
×
Clear all
No trials found.